Long-term results of a phase 2 trial of crenolanib combined with 7+3 chemotherapy in adults with newly diagnosed FLT3 mutant AML Meeting Abstract
| Authors: | Wang, E. S.; Goldberg, A. D.; Walter, R. B.; Collins, R.; Stone, R. M. |
| Abstract Title: | Long-term results of a phase 2 trial of crenolanib combined with 7+3 chemotherapy in adults with newly diagnosed FLT3 mutant AML |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301908 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.7007 |
| Notes: | Meeting Abstract: 7007 -- Meeting also held virtually -- Source: Wos |
